Fitch Affirms AmerisourceBergen at 'A-'; Outlook Negative

Go back to Fitch Affirms AmerisourceBergen at 'A-'; Outlook Negative

Leerink Partners Remains Sidelined on Express Scripts (ESRX) Following MEDACorp Call

January 22, 2016 9:59 AM EST

Leerink Partners reiterated a Market Perform rating and $80.00 price target on Express Scripts (NASDAQ: ESRX) following a MEDACorp call with three PBM specialists. The specialists indicated that 5-7% in savings during a price check is somewhat common, and one of the specialists indicated that his price check with ESRX in mid-2015... More